Table of Contents The Commanders and Chiefs From the presidents of major pharmaceutical companies to top executives at specialty and biotechnology companies to the leaders of companies that support the industry, these men and women are shaping the life-sciences industry. The Risk Takers The architects of new companies and business models who dared to take the entrepreneurial plunge inspire the industry with their innovative approaches to solving business challenges. The Researchers & Scientists Whether they are in the clinic or looking through a microscope, these men and women are pushing research and science forward in interesting and nontraditional ways to deliver safe and clinically differentiated medicines. The Practitioners Physicians are often at the forefront of changing healthcare trends, and these two practitioners are leading the way in their respective fields of medicine. The Brand Builders The strategy has been set, the R&D hurdles overcome, and the regulatory constraints tackled — now the mission is to get medications into the hands of patients. Taking advertising, creativity, marketing, and sales to the next level, these brand builders are the champions of many of today’s leading pharmaceutical brands. The Technologists Undaunted by the challenge of moving an industry that is generally slow to change, these vanguards are pushing the technology envelope to improve processes throughout the life-sciences continuum. The Mentors Though their responsibilities are vast and time-consuming, these men and women have gladly taken on the role of mentor to guide the professional development of the new recruits to the life sciences. The Change Agents Dissatisfied with the status quo, these individuals are transforming the industry by taking new approaches to solving existing and future challenges. In Every Issue Letter from the Editor Novartis’ Dr. Daniel Vasella believes people can achieve extraordinary things. MediciGroup’s Elizabeth Moench considers the patient’s perspective. Roche’s Dr. Eduard Holdener embraces out-of-the-box R&D thinking. Special Issue PharmaVOICE 100 August 2005 Wyeth’s Dr. Robert Ruffolo Jr. solicits candid feedback. Abelson-Taylor’s Jay Carter is a creative guru.
